Cellares

📍 South San Francisco, United States🗓 Founded 2019👥 249 employees💰 Last funded 2022
Pharmaceutical Manufacturing🌐 cellares.com
Website LinkedIn
Cellares is the first Integrated Development and Manufacturing Organization (IDMO) and takes an Industry 4.0 approach to mass manufacturing the living drugs of the 21st century. The company is both developing and operating integrated technologies for cell therapy manufacturing to accelerate access to life-saving cell therapies. The company’s Cell Shuttle integrates all the technologies required for the entire manufacturing process in a flexible and high-throughput platform that delivers true walk-away, end-to-end automation. Cell Shuttles will be deployed in Cellares’ Smart Factories around the world to meet total patient demand for cell therapies at global scale. Partnering with Cellares enables academics, biotechs, and pharma companies to accelerate drug development and scale out manufacturing, lower process failure rates, lower manufacturing costs, and meet global patient demand. The company is headquartered in South San Francisco, California with its commercial-scale IDMO Smart Factory in Bridgewater, New Jersey. The company is backed by world-class investors and has raised over $355 million in financing.
2
Total investors
1
Early stage
1
Mid stage
0
Late stage
2019
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
2
Frequently asked questions
Who invested in Cellares?
Cellares has 2 investors on record on gritt.io, including 1 early-stage backers, 1 mid-stage.
When did Cellares last raise funding?
The most recent investment in Cellares recorded on gritt.io was in 2022.
When was Cellares founded?
Cellares was founded in 2019.
What industry is Cellares in?
Cellares operates in Pharmaceutical Manufacturing. Find similar Pharmaceutical Manufacturing investors on gritt.io.
Where is Cellares based?
Cellares is headquartered in South San Francisco, United States.